Pitavastatin Reduces Major Atherosclerotic Cardiovascular Events in Adults with HIV
- PMID: 40854701
- DOI: 10.3122/jabfm.2025.250014R0
Pitavastatin Reduces Major Atherosclerotic Cardiovascular Events in Adults with HIV
Abstract
Initiation of pitavastatin in adults aged 40 to 75 living with HIV treated with highly active antiretroviral therapy (HAART) with low-to-moderate 10-year atherosclerotic cardiovascular disease (ASCVD) risk decreases the incidence of major cardiovascular events (MACE).
Keywords: HIV; Hyperlipidemia; Statin.
© 2025 Copyright by the American Board of Family Medicine.
Conflict of interest statement
Funding: None. The authors declare no conflict of interest.
MeSH terms
Substances
LinkOut - more resources
Medical